An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Newman, Aaron M, Bratman, Scott V, To, Jacqueline, Wynne, Jacob F, Eclov, Neville C W, Modlin, Leslie A, Liu, Chih Long, Neal, Joel W +6 more·2014·Nature Medicine

DOI 10.1038/nm.3519

Cited by (1,002)

Items 501–600 of 1,002

Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients
Anne Winther‐Larsen, Christina Demuth, Joan Fledelius, Anne Tranberg Madsen, Karin Hjorthaug, Peter Meldgaard, Boe Sandahl Sørensen · 2017 · British Journal of Cancer
Combination Approach for Detecting Different Types of Alterations in Circulating Tumor DNA in Leiomyosarcoma
Joanna Przybył, Jacob J. Chabon, Lien Spans, Kristen Nooshin Ganjoo, Sujay Vennam, Aaron M. Newman, Erna Forgó, Sushama Varma, Shirley Zhu, Maria Dêbiec‐Rychter et al. · 2018 · Clinical Cancer Research
Cell-free DNA technologies for the analysis of brain cancer
Richard James Mair, Florent C. Mouliere · 2021 · British Journal of Cancer
Promises and pitfalls of multi-cancer early detection using liquid biopsy tests
Jonathan C. M. Wan, Peter David Sasieni, Nitzan Rosenfeld · 2025 · Nature Reviews Clinical Oncology
Assessment of DNA Integrity, Applications for Cancer Research
Eleonora Zonta, Philippe Nizard, Valérie Taly · 2015 · Advances in clinical chemistry
Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients
Anja Lisa Riediger, Steffen Dietz, Uwe Bernd Schirmer, Michael A. Meister, Ingrid Heinzmann-Groth, Marc Andre Schneider, Thomas Muley, Michael Thomas, Holger Sültmann · 2016 · Scientific Reports
Liquid biopsy genotyping in lung cancer: ready for clinical utility?
Wei-Lun Huang, Yi-Lin Chen, Szu‐Chun Yang, Chung‐Liang Ho, Fang Wei, David T. Wong, Wu‐Chou Su, Chien‐Chung Lin · 2017 · Oncotarget
Characterization of background noise in capture-based targeted sequencing data
Gahee Park, Joo Kyung Park, Seung‐Ho Shin, Hyo-Jeong Jeon, Nayoung K. D. Kim, Yeon Jeong Kim, Hyun‐Tae Shin, Eunjin Lee, Kwang Hyuck Lee, Dae‐Soon Son et al. · 2017 · Genome biology
ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective Trials
Johannes Noé, Alex Lovejoy, Sai‐Hong Ignatius Ou, Stephanie J. Yaung, Walter Bordogna, Daniel M. Klass, Craig A. Cummings, Alice Tsang Shaw · 2019 · Journal of Thoracic Oncology
Perspectives of the Application of Liquid Biopsy in Colorectal Cancer
Yuhan Ding, Wenxia Li, Kun Wang, Chang Xu, Mengdi Hao, Lei Ding · 2020 · BioMed Research International
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study
Shuta Ohara, Kenichi Suda, Kazuko Sakai, Masaya Nishino, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Toshio Fujino, T. Koga, Akira Hamada et al. · 2020 · Translational Lung Cancer Research
Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)
Qian Ge, Zhiyun Zhang, Suo-Ni Li, Jiequn Ma, Zheng Zhao · 2024 · Oncology Letters
Monitoring multiple myeloma by quantification of recurrent mutations in serum
Even Holth Rustad, Eivind Coward, Emilie Ranheim Skytøen, Kristine Misund, Toril Holien, Therese Standal, Magne Børset, Vidar Beisvåg, Ola Myklebost, Leonardo A. Meza‐Zepeda et al. · 2017 · Haematologica
“Sample-to-Answer” Detection of Rare ctDNA Mutation from 2 mL Plasma with a Fully Integrated DNA Extraction and Digital Droplet PCR Microdevice for Liquid Biopsy
Zhi Geng, Shanglin Li, Lingxiang Zhu, Zhen Cheng, Min Jin, Baoxia Liu, Yong Sheng Guo, Peng Liu · 2020 · Analytical Chemistry
The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review
Sakti Chakrabarti, Hao Xie, Raul A. Urrutia, Amit Mahipal · 2020 · Cancers
Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer
Haiming Huang, Haixia Li · 2020 · 癌症：英文版
Using cell-free DNA for HCC surveillance and prognosis
Nguyen H. Tran, John B. Kisiel, Lewis Rowland Roberts · 2021 · JHEP Reports
Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to AssessEGFRMutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors
Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Erina Takai, Kuniko Sunami, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Shun-ichi I. WATANABE et al. · 2016 · The Oncologist
Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection
Klaus Pantel · 2016 · PLoS Medicine
Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics
Dia Advani, Sudhanshu Sharma, Smita Kumari, Rashmi K. Ambasta, Pravir Kumar · 2021 · Anti-Cancer Agents in Medicinal Chemistry
Liquid biopsy in cholangiocarcinoma: Current status and future perspectives
Gianluca Rompianesi, Marcello Di Martino, Alex Nicolas Gordon-Weeks, Roberto Montalti, Roberto Ivan TROISI · 2021 · World Journal of Gastrointestinal Oncology
Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA
Mohammad Amin Kerachian, Marjan Azghandi, Sina Mozaffari‐Jovin, Alain Roger Thierry · 2021 · Clinical Epigenetics
Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
Jiří Polívka, Martin Pešta, Filip Jankú · 2015 · Expert Review of Molecular Diagnostics
Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens
Judith N. Müller, Markus Falk, Jatin Talwar, Nicole Neemann, Erika Mariotti, Miriam Bertrand, Tobias Zacherle, Sotirios Lakis, Roopika Menon, Christian Gloeckner et al. · 2017 · Journal of Thoracic Oncology
Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma
Ashleigh Cavell McEvoy, Leslie Calapre, Michelle R. Pereira, Tindaro M. Giardina, Cleo Robinson, Muhammad Adnan Khattak, Tarek M. Meniawy, Antonia L. Pritchard, Nicholas K. Hayward, Benhur Amanuel et al. · 2017 · Oncotarget
Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer
Tilman Todenhöfer, Werner Jan Struss, Roland Seiler, Alexander William Wyatt, Peter C. Black · 2018 · Bladder Cancer
Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients
Gahee Park, Joo Kyung Park, Dae‐Soon Son, Seung‐Ho Shin, Yeon Jeong Kim, Hyo-Jeong Jeon, Jae Lee, Woong‐Yang Park, Kwang Hyuck Lee, Donghyun Park · 2018 · Scientific Reports
Cell-free DNA and RNA—measurement and applications in clinical diagnostics with focus on metabolic disorders
Markus Drag, Tuomas O. Kilpeläinen · 2020 · Physiological Genomics
Pathologists and liquid biopsies: to be or not to be?
Paul M Hofman, Helmut Popper · 2016 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Molecular diagnostics of lung cancer in the clinic
Lynette Marie Sholl · 2017 · Translational Lung Cancer Research
A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers
Bob T. Li, Alexander Edward Dela Cruz Drilon, Melissa Lynne Johnson, Meier Hsu, Camelia S. Sima, C. McGinn, H. Sugita, Mark G. Kris, Christopher G. Azzoli · 2015 · Annals of Oncology
Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications
Benoît Busser, Julien Lupo, Lucie Sancey, Stéphane Mouret, Patrice Faure, Joël Plumas, Laurence Chaperot, M.‐T. Leccia, Jean‐Luc Coll, Amandine Hurbin et al. · 2017 · BioMed Research International
Comparison of plasma to tissue DNA mutations in surgical patients with non–small cell lung cancer
Kezhong Chen, Jingbo Zhang, Tian Guan, Fan Yang, Feng Lou, Wei Chen, Mingyu Zhao, Jay Zhang, Siyi Chen, Jun Wang · 2017 · Journal of Thoracic and Cardiovascular Surgery
Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity
Ni Ni Moe Myint, Ajay Mark Verma, Daniel Fernández-García, Panchali B. Sarmah, Patrick S. Tarpey, Saif Sattar Al-Aqbi, Hong Cai, Ricky M. Trigg, Kevin West, Lynne M. Howells et al. · 2018 · Cell Death and Disease
Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers
Olatunji Boladale Alese, Natalie Cook, Ana Ortega Franco, Mark Bilinyi Ulanja, Lavinia Tan, Jeanne Tie · 2022 · American Society of Clinical Oncology Educational Book
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
Lavinia Tan, Ben Tran, Jeanne Tie, Ben Markman, Sumi Ananda, Niall Christopher Tebbutt, Michael Michael, Emma K. Link, Stephen Q. Wong, Sushma Chandrashekar et al. · 2023 · Clinical Cancer Research
Amplifying mutational profiling of extracellular vesicle mRNA with SCOPE
Jayeon Song, Mi Hyeon Cho, Hayoung Cho, Younseong Song, Sung-Woon Lee, Ho Chul Nam, Tae-Ho Yoon, Jong Cheol Shin, Jae‐Sang Hong, Yejin Kim et al. · 2024 · Nature Biotechnology
The minimal amount of starting DNA for Agilent’s hybrid capture-based targeted massively parallel sequencing
Jongsuk Chung, Dae‐Soon Son, Hyo-Jeong Jeon, Kyoung‐Mee Kim, Gahee Park, Gyu Ha Ryu, Woong‐Yang Park, Donghyun Park · 2016 · Scientific Reports
Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer
Heather Anne Parsons, Julia A. Beaver, Ashley Cimino‐Mathews, Siraj Mahamed Ali, Jennifer E. Axilbund, David T. W. Chu, Roisín M. Connolly, Rory L. Cochran, Sarah Croessmann, Travis A. Clark et al. · 2016 · Clinical Cancer Research
MAGERI: Computational pipeline for molecular-barcoded targeted resequencing
Mikhail Shugay, Andrew R. Zaretsky, Dmitry A. Shagin, Irina A. Shagina, Ivan A. Volchenkov, Andrey A. Shelenkov, Mikhail Y. Lebedin, Dmitriy V. Bagaev, Sergey Lukyanov, Dmitriy M. Chudakov · 2017 · PLoS Computational Biology
Current and emerging biomarkers in tumors of the central nervous system: Possible diagnostic, prognostic and therapeutic applications
Ishaq Nasib Khan, Najeeb Ullah, Deema M. Hussein, Kulvinder Singh Saini · 2017 · Seminars in Cancer Biology
Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients
E. Christensen, I. Nordentoft, S. Vang, K. Birkenkamp-Demtröder, J. B. Jensen, M. Agerbæk, J. S. Pedersen, L. Dyrskjøt · 2018 · Scientific Reports
Impact of Polymerase Fidelity on Background Error Rates in Next-Generation Sequencing with Unique Molecular Identifiers/Barcodes
S. Filges, Emiko Yamada, A. Ståhlberg, T. Godfrey · 2019 · Scientific Reports
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors
César Serrano, Ana P. Vivancos, Antonio Lopez Pousa, Judit Matito, Francesco Mattia Mancuso, Claudia María Valverde, Sergi Quiroga, Stefania Landolfi, Sandra Castro, Cristina Dopazo et al. · 2020 · BMC Cancer
Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers
Manuel Caitano Maia, Meghan M. Salgia, Sumanta Kumar Pal · 2020 · Nature Reviews Urology
Serial ultra‐deep sequencing of circulating tumor DNA reveals the clonal evolution in non‐small cell lung cancer patients treated with anti‐PD1 immunotherapy
Li Li, Yubo Wang, Weiwei Shi, Mengxiao Zhu, Zhulin Liu, Nuo Luo, Yanwu Zeng, Yong He · 2019 · Cancer Medicine
FinaleDB: a browser and database of cell-free DNA fragmentation patterns
Haizi Zheng, Michelle S Zhu, Yaping Liu · 2020 · Bioinformatics
Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early-stage lung cancer and postoperative minimal residual disease
Yun Li, Guanchao Jiang, Wendy Yi-Ying Wu, Hao Yang, Yichen Jin, Manqi Wu, Wenjie Liu, Airong Yang, Olga Chervova, Sujie Zhang et al. · 2023 · EBioMedicine
Clinical potential of gene mutations in lung cancer
Miranda B. Carper, Pier Paolo Claudio · 2015 · Clinical and Translational Medicine
Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced Cancer
Filip Jankú, Shile Zhang, Jill Waters, Li Liu, Helen J. Huang, Vivek Subbiah, David S. Hong, Daniel D. Karp, Siqing Fu, Xuyu Cai et al. · 2017 · Clinical Cancer Research
Cell-free DNA in cancer: current insights
Heidi Fettke, Edmond M. Kwan, Arun Azad · 2018 · Cellular Oncology
Circulating tumor DNA analysis in the era of precision oncology
Rabih Said, Nicolas Marie Guibert, Geoffrey R. Oxnard, Apostolia Maria Tsimberidou · 2020 · Oncotarget
Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications
Srinivasan Yegnasubramanian, Angelo Michael De Marzo, William G. Nelson · 2018 · Cold Spring Harbor Perspectives in Medicine
Early detection of cancer using circulating tumor DNA: biological, physiological and analytical considerations
Abel Jacobus Bronkhorst, Vida Ungerer, Stefan Holdenrieder · 2019 · Critical Reviews in Clinical Laboratory Sciences
ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With Chemotherapy
Wei Zou, Stephanie J. Yaung, Frederike Fuhlbrück, Marcus D. Ballinger, Eric J Peters, John F. Palma, David S. Shames, David R. Gandara, Yuqiu Jiang, Namrata S. Patil · 2021 · JCO Precision Oncology
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
Guiqi Zhu, Weiren Liu, Zheng Tang, Wei‐Feng Qu, Yuan Fang, Xi‐Fei Jiang, Shushu Song, Han Wang, Chenyang Tao, Pei‐Yun Zhou et al. · 2021 · Molecular Oncology
Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients
Steffen Dietz, Uwe Bernd Schirmer, Clémentine Mercé, Nikolas C. C. von Bubnoff, Edgar Dahl, Michael A. Meister, Thomas Muley, Michael Thomas, Holger Sültmann · 2016 · PLoS ONE
Patient monitoring through liquid biopsies using circulating tumor DNA
Peter Ulz, E. Heitzer, J. Geigl, M. Speicher · 2017 · International Journal of Cancer
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy
Daniel H. Hovelson, Chia‐Jen Liu, Yugang Wang, Qing Kang, James Henderson, Amy M. Gursky, Scott Brockman, Nithya Ramnath, John C. Krauss, Moshe Talpaz et al. · 2017 · Oncotarget
Developing biomarker-specific end points in lung cancer clinical trials
Neal, Joel W., Gainor, Justin F., Shaw, Alice T. · 2015 · Nature Reviews Clinical Oncology
Genetic profiling of cancer with circulating tumor DNA analysis
Ling Lu, Junqin Bi, Liming Bao · 2018 · Journal of genetics and genomics/Journal of Genetics and Genomics
Experimental Comparison in Sensing Breast Cancer Mutations by Signal ON and Signal OFF Paper-Based Electroanalytical Strips
Stefano Cinti, Giulia Cinotti, Claudio Parolo, Emily P. Nguyen, Veronica Caratelli, Danila Moscone, Fabiana Arduini, Arben Merkoçi · 2019 · Analytical Chemistry
Synergistic action of image-guided radiotherapy and androgen deprivation therapy
Jennifer A. Locke, Alan Dal Pra, Stéphane Supiot, Padraig Richard Warde, Robert Glen Bristow · 2015 · Nature Reviews Urology
Cell-Free DNA Kinetics in a Pre-Clinical Model of Head and Neck Cancer
Nidal Muhanna, Marco A. Di Grappa, Harley H. L. Chan, Tahsin M. Khan, Cheng S. Jin, Yangqiao Zheng, Jonathan Crawford Irish, Scott Victor Bratman · 2017 · Scientific Reports
Functional significance of U2AF1 S34F mutations in lung adenocarcinomas
Mohammad Shahrokh Esfahani, Luke J. Lee, Young-Jun Jeon, Ryan A. Flynn, Henning Stehr, Angela Bik‐Yu Hui, Noriko Ishisoko, Eric Kildebeck, Aaron M. Newman, Scott Victor Bratman et al. · 2019 · Nature Communications
Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer
Misty Dawn Shields, Kevin Chen, Giselle Dutcher, Ishika Patel, Bruna Pellini · 2022 · International Journal of Molecular Sciences
Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception
Arielle J. Medford, Beverly Moy, Laura M. Spring, Sara Alsterlind Hurvitz, Nicholas C. Turner, Aditya Bardia · 2023 · Clinical Cancer Research
Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer – a comprehensive review
Kim-Lea Reese, Klaus Pantel, Daniel J. Smit · 2024 · Journal of Experimental & Clinical Cancer Research
Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer
Erina Takai, Shinichi Yachida · 2016 · World Journal of Gastroenterology
Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma
Soo‐Ryum Yang, Chieh‐Yu Lin, Henning Stehr, Steven Long, Christina S. Kong, Gerald J. Berry, James L. Zehnder, Christian A. Kunder · 2017 · Journal of Molecular Diagnostics
Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer
Richard M. Goldberg, Clara O. Montagut, Zev A. Wainberg, Philippe Ronga, Françis Audhuy, Julien Taı̈eb, Sebastian Stintzing, Salvatore Siena, Daniele Santini · 2018 · ESMO Open
Detecting tumour response and predicting resectability after neoadjuvant therapy for borderline resectable and locally advanced pancreatic cancer
Savio George Barreto, Benjamin P. T. Loveday, John Albert Windsor, Sanjay Pandanaboyana · 2018 · ANZ Journal of Surgery
Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems
Kamil Reza Khondakar, Shuvashis Dey, Alain Wuethrich, Abu Ali Ibn Sina, Matt Trau · 2019 · Accounts of Chemical Research
Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer Patients
Leila Jahangiri, Tara Patricia Hurst · 2019 · Cancers
ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine
Bruna Pellini, Nadja Pejovic, Wenjia Feng, Noah J. Earland, Peter K. W. Harris, Abul Usmani, Jeffrey J. Szymanski, Faridi Qaium, Jacqueline L. Mudd, Marvin Petty et al. · 2021 · JCO Precision Oncology
Current status of ctDNA in precision oncology for hepatocellular carcinoma
Yan Li, Yuanyuan Zheng, Liwei Wu, Jingjing Li, Jie Ji, Qiang Yu, Weiqi Dai, Jiao Feng, Jianye Wu, Chuanyong Guo · 2021 · Journal of Experimental & Clinical Cancer Research
Ratiometric Electrochemical Switch for Circulating Tumor DNA through Recycling Activation of Blocked DNAzymes
Hua Chai, Yuguo Tang, Zhenzhen Guo, Peng Miao · 2022 · Analytical Chemistry
Circulating Biomarkers in Non–Small-Cell Lung Cancer: Current Status and Future Challenges
Alexios Matikas, Konstantinos Nikolaos Syrigos, Sofia Agelaki · 2016 · Clinical Lung Cancer
Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution
Ravi G. Gupta, Robert A. Somer · 2017 · Molecular Cancer Research
Circulating tumor DNA in blood: Future genomic biomarkers for cancer detection
Sumbal Sumbal, Aneeqa Javed, Bakht Afroze, Hafiza Fizzah Zulfiqar, Faqeeha Javed, Sobia Noreen, Bushra Ijaz · 2018 · Experimental Hematology
Fabrication of DNAzyme-functionalized hydrogel and its application for visible detection of circulating tumor DNA
Xiaoxia Mao, Shaobing Pan, Duoqi Zhou, Xiaowu He, Yuanguang Zhang · 2019 · Sensors and Actuators B Chemical
Molecular biomarkers in early stage lung cancer
M. Fernández Rodríguez, Daniel Ajona, Luis Miguel Seijo, Julián Sanz‐Ortega, Karmele Valencia, Jesus Corral, Miguel Mesa, Rubén Pı́o, Alfonso Calvo, María D. Lozano et al. · 2021 · Translational Lung Cancer Research
Sequencing-based measurable residual disease testing in acute myeloid leukemia
Yoest, Jennifer M., Shirai, Cara Lunn, Duncavage, Eric J. · 2020 · Frontiers in Cell and Developmental Biology
A new generation of cancer genome diagnostics for routine clinical use: overcoming the roadblocks to personalized cancer medicine
Johannes M. Heuckmann, Roman Kurt Thomas · 2015 · Annals of Oncology
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA
Steffen Dietz, Petros Christopoulos, Zhao Kang Yuan, Arlou Kristina Angeles, Lisa Gu, Anna‐Lena Volckmar, Simon J. Ogrodnik, Florian Janke, Chiara Dalle Fratte, Tomasz Żemojtel et al. · 2020 · EBioMedicine
Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology
Eser Kırkızlar, Bernhard G Zimmermann, Tudor P. Constantin, Ryan Swenerton, Bin Hoang, Nicholas P. Wayham, Joshua Babiarz, Zachary Demko, Robert J. Pelham, Stephanie Kareht et al. · 2015 · Translational Oncology
Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer
Ekkehard Schütz, Mohammad Reza Akbari, Julia Beck, Howard B. Urnovitz, William Zhang, Kirsten Bornemann-Kolatzki, William Marvin Mitchell, Robert K. Nam, Steven Alexander Narod · 2014 · Clinical Chemistry
Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
Jiacheng Tang, Yi-Li Feng, Tao Guo, Anyong Xie, Xiujun Cai · 2016 · Cell & Bioscience
Future of Liquid Biopsies With Growing Technological and Bioinformatics Studies: Opportunities and Challenges in Discovering Tumor Heterogeneity With Single-Cell Level Analysis
Naveen Ramalingam, Stefanie S. Jeffrey · 2018 · The Cancer Journal
Liquid Biopsy in Thyroid Cancer: New Insight.
Fatemeh Khatami, Seyed Mohammad Tavangar · 2018 · Europe PMC (PubMed Central)
Liquid biopsy for pediatric central nervous system tumors
Erin R. Bonner, Miriam Bornhorst, Roger J. Packer, Javad Nazarian · 2018 · npj Precision Oncology
Circulating tumor DNA analysis for tumor diagnosis
Yihui Wang, Zhen Song, Xinyuan Hu, Huai‐Song Wang · 2021 · Talanta
Pathophysiology of ctDNA Release into the Circulation and Its Characteristics: What Is Important for Clinical Applications
Nickolas Papadopoulos · 2019 · Recent results in cancer research/Recent Results in Cancer Research
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis
Carmine Valenza, Erick Figueiredo Saldanha, Y. Gong, Pietro De Placido, David Gritsch, H. Ortiz, Dario Trapani, Fabio Conforti, Chiara Cremolini, S. Peters et al. · 2025 · Annals of Oncology
Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls
Shu Xia, Chiang‐Ching Huang, Min Le, Rachel L. Dittmar, Meijun Du, Tiezheng Yuan, Yongchen Guo, Yuan Wang, Xuexia Wang, Susan Tsai et al. · 2015 · Lung Cancer
Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma
Honglei Luo, Hong Li, Zhaoyang Hu, Hongjin Wu, Chenglin Liu, Ying Li, Xiaoyan Zhang, Ping Lin, Qiang Hou, Guohui Ding et al. · 2016 · Biochemical and Biophysical Research Communications
Ultrasensitive colorimetric detection of circulating tumor DNA using hybridization chain reaction and the pivot of triplex DNA
Ruimin Li, Li Zou, Yanwei Luo, Manjun Zhang, Liansheng Ling · 2017 · Scientific Reports
Liquid biopsy: unlocking the potentials of cell-free DNA
David T. W. Chu, Ben Ho Park · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis
Yue Zhao, Junying He, Yueli Zou, Xiaosu Guo, Junzhao Cui, Li Guo, Hui Bu · 2019 · BMC Neurology
Delineating the evolutionary dynamics of cancer from theory to reality
Ivana Božić, Catherine J. Wu · 2020 · Nature Cancer